Please call back later <a href=" http://www.artdentistry.co.uk/bimatoprost-generic-uk.pdf ">bimatoprost generic uk</a> Revenue for the company's second quarter, which ended on Aug. 31, was approximately $1.6 billion, down 45 percent from the same period a year earlier. Both the operating loss and the revenue were in line with preliminary results released last week.